Antiviral drug Triazavirin, selectively labeled with .sup.2H, .sup.13C, and .sup.15N stable isotopes. Synthesis and properties

Isotope-labeled antiviral drug Triazavirin containing .sup.2H, .sup.13C, and .sup.15N atoms in its structure has been synthesized. .sup.13C.sup.2H.sub.3I and KS.sup.13CN served as donors of .sup.13C isotopes. The use of .sup.13С-MeI containing .sup.2H atoms made it possible to additionally incorpor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemistry of heterocyclic compounds (New York, N.Y. 1965) N.Y. 1965), 2021-04, Vol.57 (4), p.479
Hauptverfasser: Shestakova, Tatyana S, Deev, Sergey L, Khalymbadzha, Igor Ð, Rusinov, Vladimir L, Paramonov, Alexander S, Arseniev, Alexander S, Shenkarev, Zakhar O
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Isotope-labeled antiviral drug Triazavirin containing .sup.2H, .sup.13C, and .sup.15N atoms in its structure has been synthesized. .sup.13C.sup.2H.sub.3I and KS.sup.13CN served as donors of .sup.13C isotopes. The use of .sup.13С-MeI containing .sup.2H atoms made it possible to additionally incorporate deuterium labels into the structure of the compound. The .sup.15N atoms were incorporated using .sup.15N-enriched sodium nitrite, aminoguanidine carbonate, and ethyl nitroacetate. The resulting .sup.2H.sub.3,.sup.13C.sub.2,.sup.15N.sub.3-Triazavirin was characterized by NMR spectroscopy.
ISSN:0009-3122
DOI:10.1007/s10593-021-02927-1